Author

P. A. Gallay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

M. D. Bobardt· 2 shared A. Castellarnau· 1 shared A. K. Chatterjee· 1 shared C. A. Luscombe· 1 shared D. Jochmans· 1 shared D. Ure· 1 shared G. P. Heery· 1 shared J. K. Fairley· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. D. Bobardt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity

P. A. Gallay, W. Stauffer, M. Bobardt, D. Ure, R. Foster

This study shows that rencofilstat reduces HCV-induced HCC independently of its antiviral activity, making it a potential therapeutic agent for HCC.

bioRxiv · Aug 19, 2023Microbiology

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

T. N. D. Do, K. Donckers, L. Vangeel, A. K. Chatterjee, P. A. Gallay, M. D. Bobardt, J. P. Bilello, T. Cihlar, S. De Jonghe, J. Neyts, D. Jochmans

This study develops a SARS-CoV-2 replication model using primary human airway epithelial cells to test antiviral agents, finding that remdesivir and interferons inhibit replication while AT-511 does not.

bioRxiv · Mar 25, 2021Microbiology

Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

J. R. A. Paull, G. P. Heery, M. D. Bobardt, A. Castellarnau, C. A. Luscombe, J. K. Fairley, P. A. Gallay

This study evaluates astodrimer sodium's in vitro antiviral and virucidal activity against SARS-CoV-2, showing potent inhibition of replication and infectivity with high selectivity.

bioRxiv · Aug 20, 2020Microbiology